封面
市場調查報告書
商品編碼
1634185

全球 MRI 線圈市場 - 2025 - 2033

Global MRI Coils Market - 2025 - 2033

出版日期: | 出版商: DataM Intelligence | 英文 159 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024年,全球MRI線圈市場規模達92.6億美元,預計2033年將達到181.8億美元,2025-2033年預測期間複合年成長率為8.1%。

MRI 線圈是磁振造影 (MRI) 系統的關鍵組件,可實現不同身體部位的高品質診斷影像。 MRI 線圈是一種專用設備,其工作原理與天線類似。它們由一圈或多圈銅線組成,有助於在 MRI 掃描期間創建和接收射頻 (RF) 訊號。這些線圈對於成像過程至關重要,因為它們能夠捕捉人體原子核在強磁場作用下釋放的訊號。

MRI 線圈接收 MRI 機器產生的射頻訊號並將其傳輸到電腦,在電腦中對訊號進行處理以提供身體內部結構的詳細影像。線圈有多種設計,適合某些解剖位置。有些線圈是框架狀的,適合被掃描的區域,但其他線圈是靈活的,可以根據身體的形狀進行調整。

市場動態:

驅動程式和限制

對 MRI 線圈的需求不斷增加

對 MRI 線圈的需求不斷成長預計將成為全球 MRI 線圈市場成長的重要因素。全球 MRI 線圈市場預計將大幅擴張,這主要是由於對診斷成像程序的需求不斷增加、慢性病患病率不斷上升、技術進步以及新產品的推出和批准。由於人口老化、生活方式的改變和環境影響,心血管疾病、癌症和神經系統疾病等慢性疾病呈上升趨勢。

例如,根據美國疾病管制與預防中心的數據,大約 2,010 萬名 20 歲及以上的成年人患有冠狀動脈疾病,這一比例在美國約為 7.2%。根據國家生物技術資訊中心的數據,2023 年,骨質疏鬆症是全球和熱帶國家最常見的代謝性骨病。停經後女性骨質疏鬆症盛行率為30%至50%,50歲以上男性骨質疏鬆症盛行率高達20%。此外,據世界衛生組織稱,到2023 年,癌症、慢性阻塞性肺病、哮喘、糖尿病和心血管疾病等疾病影響低收入和中等收入國家的人們,這些國家的非傳染性疾病死亡人數佔全球非傳染性疾病死亡人數的四分之三以上(31.4萬)發生,四捨五入到80%。大約 1700 萬人在 70 歲之前死於非傳染性疾病。隨著慢性病盛行率的上升,醫療機構正在逐步實施 MRI 技術,以提高診斷準確性和治療計劃。

MRI 線圈市場也受到技術改進的推動,這些技術改進增強了這些設備的設計和功能。由於更高的信噪比 (SNR) 和更快的掃描時間等創新,MRI 掃描變得更有效率和更有效。隨著製造商製造出專門針對特定應用的新型射頻 (RF) 線圈和梯度線圈,影像品質不斷提高,這對於識別複雜的慢性病至關重要。此外,高場 MRI 系統(例如 3T 和 7T 機器)的結合可提供更清晰、更詳細的影像,從而提高成像能力,這對於檢測與慢性疾病相關的細微變化至關重要。

例如,2023 年 11 月,全球健康科技先驅皇家飛利浦推出了三款新型 MR Smart Fit 線圈,非常適合其預期用途。射頻線圈是所有 MRI 掃描的基本組成部分。新型超輕量線圈具有卓越的靈活性,可顯著減少患者設定時間,並透過飛利浦的 SmartSpeed AI 解決方案進行最佳化,從而實現更高的影像品質解析度並提高醫療保健從業人員的診斷信心。

設備成本高

設備成本高等因素預計將阻礙全球 MRI 線圈市場。購買和維護 MRI 線圈的成本可能很高,特別是對於資金有限的低度開發國家的醫療機構。 MRI 線圈的成本差異很大,新設備的價格從 12,000 美元到 120,000 美元不等。相比之下,翻新卷材價格更實惠,但仍需要大量投資,投資金額從 3,000 美元到 25,000 美元不等。這些費用可能會減緩新技術的採用,特別是在醫療融資有限且財務限制普遍存在的發展中國家。因此,許多醫院可能會選擇使用舊設備或翻新線圈,而不是投資最新技術,導致地區之間診斷能力的不平等。

目錄

第 1 章:方法與範圍

第 2 章:定義與概述

第 3 章:執行摘要

第 4 章:動力學

  • 影響因素
    • 促進要素
    • 對 MRI 線圈的需求不斷增加
    • 限制
    • MRI 線圈成本高
    • 機會
    • 影響分析

第 5 章:產業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析
  • 報銷分析
  • 專利分析
  • SWOT分析
  • DMI 意見

第 6 章:按線圈類型

  • 射頻線圈
  • 梯度線圈
  • 地表線圈
  • 其他

第 7 章:按申請

  • 神經病學
  • 心血管
  • 脊椎和肌肉骨骼
  • 兒科
  • 胸部
  • 腹部
  • 其他

第 8 章:最終用戶

  • 醫院
  • 診斷影像中心
  • 其他

第 9 章:按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲

第 10 章:競爭格局

  • 競爭場景
  • 市場定位/佔有率分析
  • 併購分析

第 11 章:公司簡介

  • GE HealthCare
    • 公司概況
    • 產品組合和描述
    • 財務概覽
    • 主要進展
  • Koninklijke Philips NV
  • Siemens Healthcare Private Limited
  • Canon Medical Systems
  • Esaote SPA
  • MR Instruments, Inc.
  • RAPID MR International
  • ScanMed, LLC
  • Bruker
  • Tesla Engineering Ltd

第 12 章:附錄

簡介目錄
Product Code: MD9002

The global MRI coils market reached US$ 9.26 billion in 2024 and is expected to reach US$ 18.18 billion by 2033, growing at a CAGR of 8.1% during the forecast period 2025-2033.

MRI coils are critical components of Magnetic Resonance Imaging (MRI) systems, enabling high-quality diagnostic images of diverse body areas. MRI coils are specialized devices that work similarly to antennas. They are made up of one or more loops of copper wire that help create and receive radiofrequency (RF) signals during an MRI scan. These coils are essential to the imaging process because they enable the capturing of signals released by the body's atomic nuclei when subjected to a strong magnetic field.

MRI coils receive RF signals created by the MRI machine and transmit them to a computer, where they are processed to provide detailed images of the body's internal architecture. Coils come in a variety of designs adapted to certain anatomical locations. Some coils are frame-like and fit over the area being scanned, but others are flexible and adjust to the body's shape.

Market Dynamics: Drivers & Restraints

Increasing demand for MRI coils

The increasing demand for MRI coils is expected to be a significant factor in the growth of the global MRI coils market. The global MRI coils market is poised for significant expansion, owing mostly to the increasing demand for diagnostic imaging procedures, the rising prevalence of chronic diseases, technological advancements, and new product launches and approvals. Chronic diseases such as cardiovascular disorders, cancer, and neurological conditions are on the rise as a result of aging populations, lifestyle changes, and environmental influences.

For instance, according to the Centers for Disease Control and Prevention, around 20.1 Million adults age 20 and older have coronary artery disease, about 7.2% in the United States. According to the National Center for Biotechnology Information, 2023, Osteoporosis is the most common metabolic bone disorder globally and in tropical countries. The prevalence of osteoporosis is 30 to 50% among postmenopausal women and up to 20% in men above 50 years. Furthermore, according to the World Health Organization, 2023, diseases like cancers, chronic obstructive pulmonary diseases, asthma, diabetes, and cardiovascular diseases affect people in low- and middle-income countries, where more than three-quarters of global NCD deaths (31.4 million) occur that rounds up to 80%. Approximately 17 million people die from an NCD before age 70. The increasing prevalence of such disorders needs improved imaging techniques capable of providing deep insights into patients' health, making MRI a vital tool in modern medicine. As the prevalence of chronic diseases rises, healthcare organizations are progressively implementing MRI technologies to improve diagnostic accuracy and treatment planning.

The MRI coils market is also driven by the technical improvements that enhance the design and functionality of these devices. MRI scans are becoming more efficient and effective due to innovations including higher signal-to-noise ratios (SNRs) and faster scan times. As manufacturers create novel radiofrequency (RF) coils and gradient coils specialized to specific applications, image quality increases, which is critical for identifying complex chronic conditions. Furthermore, the incorporation of high-field MRI systems (such as 3T and 7T machines) improves imaging capabilities by allowing for crisper and more detailed pictures, which are critical in detecting subtle changes associated with chronic diseases.

For instance, in November 2023, Royal Philips, a global pioneer in health technology, launched three new MR Smart Fit coils that are ideal for their intended use. RF coils are a fundamental component of all MRI scans. The new ultra-lightweight coils offer remarkable flexibility, a significant reduction in patient setup time, and optimization with Philips' SmartSpeed AI solution, resulting in higher image quality resolution and increased diagnostic confidence for healthcare practitioners.

High costs of devices

Factors such as high costs of devices are expected to hamper the global MRI coils market. The cost of purchasing and maintaining MRI coils can be high, particularly for healthcare facilities in underdeveloped countries where funds are limited. The cost of MRI coils varies greatly, with new equipment ranging from USD 12,000 to $120,000. In comparison, reconditioned coils are more affordable but still require a significant investment, ranging from USD 3,000 to USD 25,000. These expenses can slow the adoption of new technologies, especially in developing countries where healthcare financing is limited and financial restraints are common. As a result, many hospitals may choose to employ older equipment or refurbished coils rather than invest in the most recent technology, resulting in inequalities in diagnostic capabilities between regions.

Segment Analysis

The global MRI coils market is segmented based on coil type, application, end-user, and region.

Radiofrequency Coils segment is expected to dominate the global MRI coils market share

The radiofrequency coils segment is anticipated to dominate the global MRI coils market owing to its critical role in the MRI imaging process and the increasing demand for advanced diagnostic technologies. RF coils are critical components of MRI systems, serving as both transmitters and receivers of radiofrequency signals. This dual functionality enables them to produce high-quality images of inside body structures, making them valuable in medical diagnostics.

The increased preference for non-invasive diagnostic procedures contributes to the dominance of RF coils in the MRI market. Patients increasingly prefer imaging procedures that reduce inconvenience and risk while delivering detailed information about their health issues. As a result, hospitals are investing in advanced MRI systems equipped with high-quality RF coils to meet demand. The incorporation of artificial intelligence (AI) and machine learning into MRI technology is also expected to boost the capabilities of RF coils, confirming their role in current medical diagnosis.

Continuous advances in RF coil technology are strengthening their market position. Innovations include lighter and more flexible designs that improve patient comfort during scans while also increasing imaging procedure efficiency. These advancements not only improve imaging quality but also contribute to faster diagnosis and treatment planning, which is critical for efficient chronic disease management. For instance, in May 2024, a team of scientists from the German Cancer Research Center, designed an RF coil with minimal ion attenuation, based on a cylindrical 16-rung birdcage configuration. This specific birdcage coil only has capacitors on the end rings, thereby avoiding attenuation and scattering in a large window in between. The RF coil is designed to prevent adverse effects such as ion attenuation and scattering that are caused due to highly attenuating electronic components which alter the delivered dose distribution and reduce treatment efficacy.

Geographical Analysis

North America is expected to hold a significant position in the global MRI coils market share

North America will likely account for a significant share of the global MRI coils market, owing to its advanced healthcare infrastructure, increasing prevalence of chronic diseases, and substantial investments in medical technology, technological advancements, and recent launches and approvals. The rising incidence of chronic diseases has a substantial influence on healthcare services in North America. As healthcare practitioners work to enhance early diagnosis and treatment results, demand for MRI services has increased. This development is especially noticeable in hospitals and diagnostic imaging centers, which are increasingly using powerful MRI systems with complex coils. These coils serve an important role in improving image quality and delivering specific information about the medical conditions of patients.

For instance, according to an article published by the National Institute of Health, in 2024, 2,001,140 new cancer cases and 611,720 cancer deaths are projected to occur in the United States. Cancer mortality continued to decline through 2021, averting over 4 million deaths since 1991 because of reductions in smoking, earlier detection for some cancers, and improved treatment options in both adjuvant and metastatic settings. However, these gains are threatened by increasing incidence for 6 of the top 10 cancers.

The region's healthcare sector is highlighted by significant financial investments in new medical technologies, which has a direct impact on demand for MRI coils. These investments not only increase the availability of new diagnostic technologies but also ensure that healthcare facilities can meet the growing demand for imaging services. As hospitals and diagnostic centers strive to improve patient outcomes through early identification and intervention, they are increasingly relying on modern MRI systems with revolutionary coil technologies. This pattern is additionally facilitated by North America's high levels of healthcare spending, which make it easier to purchase advanced MRI equipment with sophisticated coils.

For instance, in June 2024, Promaxo, a developer of portable low-field MRI systems and minimally invasive robotics, received an investment from Zynext Ventures, the Venture Capital (VC) arm of Zydus Lifesciences. The investment from Zynext Ventures will enable Promaxo to expand its operations and accelerate development efforts in the field of advanced MRI technology.

Asia Pacific is growing at the fastest pace in the global MRI coils market

The Asia Pacific region is emerging as the fastest-growing market for MRI coils, owing to a combination of demographic trends, increased healthcare investment, recent launches, and a rising number of chronic diseases. The rising frequency of chronic diseases in the region of Asia-Pacific has increased the need for appropriate diagnostic imaging solutions. Cardiovascular diseases, cancer, and neurological disorders are becoming increasingly common, necessitating the use of modern imaging tools to accurately diagnose and plan treatments. The increased awareness of early diagnosis among patients and healthcare providers is driving up demand for MRI systems, which rely on high-quality coils to produce precise imaging results.

For instance, according to the National Institute of Health, the estimated number of incident cases of cancer in India for the year 2022 was found to be 14,61,427 (crude rate:100.4 per 100,000). In India, one in nine people is likely to develop cancer in his/her lifetime. Lung and breast cancers were the leading sites of cancer in males and females, respectively. Among the childhood (0-14 yr) cancers, lymphoid leukemia (boys: 29.2% and girls: 24.2%) was the leading site. The incidence of cancer cases is estimated to increase by 12.8 percent in 2025 as compared to 2020.

Competitive Landscape

The major global players in the global MRI coils market include GE HealthCare, Koninklijke Philips N.V, Siemens Healthcare Private Limited, Canon Medical Systems, Esaote SPA, MR Instruments, Inc., RAPID MR International, ScanMed, LLC, Bruker, Tesla Engineering Ltd among others.

Emerging Players

Innovatus Imaging and Time Medical Holding Co Ltd among others

Key Developments

  • In November 2024, Polarean Imaging PLC received FDA 510(k) clearance for its XENOVIEW 3T chest coil to be used with GE HealthCare 3 Tesla (3T) MRI systems. The clearance allows the use of the device to support lung imaging using hyperpolarised Xenon-129 for oral inhalation in adults and children aged 12 and older. It works with GE MRI models, including the SIGNA Premier 3T and Discovery MR750 3T, equipped with multi-nuclear spectroscopy.
  • In May 2024, Siemens Healthineers invested 250 million pounds ($314 million) in a facility to establish a new MRI manufacturing plant in the U.K.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global MRI coils market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Coil Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by End-User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
    • 4.1.2. Increasing Demand for MRI Coil
    • 4.1.3. Restraints
    • 4.1.4. High Costs of MRI Coils
    • 4.1.5. Opportunity
    • 4.1.6. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Reimbursement Analysis
  • 5.6. Patent Analysis
  • 5.7. SWOT Analysis
  • 5.8. DMI Opinion

6. By Coil Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Coil Type
    • 6.1.2. Market Attractiveness Index, By Coil Type
  • 6.2. Radiofrequency Coils*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Gradient Coils
  • 6.4. Surface Coils
  • 6.5. Others

7. By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Neurology*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Cardiovascular
  • 7.4. Spine and Musculoskeletal
  • 7.5. Pediatric
  • 7.6. Breast
  • 7.7. Abdominal
  • 7.8. Others

8. By End User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.1.2. Market Attractiveness Index, By End User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Diagnostic Imaging Centers
  • 8.4. Others

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Coil Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. U.S.
      • 9.2.6.2. Canada
      • 9.2.6.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Coil Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. U.K.
      • 9.3.6.3. France
      • 9.3.6.4. Spain
      • 9.3.6.5. Italy
      • 9.3.6.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Coil Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Brazil
      • 9.4.6.2. Argentina
      • 9.4.6.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Coil Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. South Korea
      • 9.5.6.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Coil Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. GE HealthCare*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
  • 11.2. Koninklijke Philips N.V
  • 11.3. Siemens Healthcare Private Limited
  • 11.4. Canon Medical Systems
  • 11.5. Esaote SPA
  • 11.6. MR Instruments, Inc.
  • 11.7. RAPID MR International
  • 11.8. ScanMed, LLC
  • 11.9. Bruker
  • 11.10. Tesla Engineering Ltd

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us